Xenon Pharmaceuticals Inc (XENE)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | SVORONOS, DAWN | Director | Common Shares | Acquisition | 5,144 | 8.15 |
| Sep 1, 2026 | SVORONOS, DAWN | Director | Stock Option (Right to Buy) | Disposal | 5,144 | 0 |
| Aug 28, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Disposal | 6,368 | 60.167 |
| Aug 28, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Disposal | 700 | 60.977 |
| Aug 11, 2026 | GANNON, STEVEN | Director | Common Shares | Disposal | 10,000 | 64.055 |
| Jun 5, 2026 | CANNON, GILLIAN | Director | Common Shares | Disposal | 1,190 | 53.14 |
| Jun 5, 2026 | PATOU, GARY | Director | Common Shares | Disposal | 1,322 | 53.14 |
| Jun 3, 2026 | GOVER, JUSTIN D. | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | MACHADO, PATRICK | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | SVORONOS, DAWN | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | GAROFALO, ELIZABETH A. | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | CANNON, GILLIAN | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | GOVER, JUSTIN D. | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | SVORONOS, DAWN | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | MACHADO, PATRICK | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | PATOU, GARY | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | CANNON, GILLIAN | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | GANNON, STEVEN | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | GAROFALO, ELIZABETH A. | Director | Share Option (Right to Buy) | Acquisition | 10,507 | 0 |
| Jun 3, 2026 | PATOU, GARY | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 3, 2026 | GANNON, STEVEN | Director | Restricted Share Units | Acquisition | 1,593 | 0 |
| Jun 1, 2026 | SVORONOS, DAWN | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | PATOU, GARY | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | CANNON, GILLIAN | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | GOVER, JUSTIN D. | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | SVORONOS, DAWN | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | CANNON, GILLIAN | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | MACHADO, PATRICK | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | GAROFALO, ELIZABETH A. | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | SVORONOS, DAWN | Director | Common Shares | Disposal | 1,416 | 53.41 |
| Jun 1, 2026 | GANNON, STEVEN | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | GANNON, STEVEN | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | MACHADO, PATRICK | Director | Common Shares | Acquisition | 2,645 | |
| Jun 1, 2026 | GAROFALO, ELIZABETH A. | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | PATOU, GARY | Director | Restricted Share Units | Disposal | 2,645 | 0 |
| Jun 1, 2026 | GANNON, STEVEN | Director | Common Shares | Disposal | 1,416 | 53.41 |
| Jun 1, 2026 | GOVER, JUSTIN D. | Director | Common Shares | Acquisition | 2,645 | |
| May 12, 2026 | GANNON, STEVEN | Director | Stock Option (Right to Buy) | Disposal | 3,500 | 0 |
| May 12, 2026 | GANNON, STEVEN | Director | Common Shares | Acquisition | 3,500 | 7.38 |
| Mar 13, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Disposal | 1,410 | 55.225 |
| Mar 13, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Common Shares | Disposal | 1,342 | 55.225 |
| Mar 13, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 7,308 | 55.225 |
| Mar 12, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Common Shares | Acquisition | 3,750 | |
| Mar 12, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Restricted Share Units | Disposal | 3,750 | 0 |
| Mar 12, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 12,500 | |
| Mar 12, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Restricted Share Units | Disposal | 3,750 | 0 |
| Mar 12, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Acquisition | 3,750 | |
| Mar 12, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Restricted Share Units | Disposal | 12,500 | 0 |
| Mar 10, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Disposal | 2,771 | 60.108 |
| Mar 10, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Common Shares | Disposal | 2,607 | 60.108 |
| Mar 10, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 11,269 | 60.108 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 2,449 | 61.26 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 12,479 | 59.5 |
| Mar 9, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Performance Share Units | Acquisition | 7,500 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 20,000 | |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 75,000 | 8.4 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Stock Option | Disposal | 65,000 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 21,791 | 58.81 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Stock Option | Disposal | 105,000 | 0 |
| Mar 9, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Common Shares | Acquisition | 7,500 | |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 65,000 | 62.06 |
| Mar 9, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Performance Share Units | Acquisition | 7,500 | 0 |
| Mar 9, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Performance Share Units | Disposal | 7,500 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Stock Option | Disposal | 25,000 | 0 |
| Mar 9, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Performance Share Units | Disposal | 7,500 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Performance Share Units | Disposal | 20,000 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 31,694 | 59.88 |
| Mar 9, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Common Shares | Acquisition | 7,500 | |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Performance Share Units | Acquisition | 20,000 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 21,515 | 60.49 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 65,000 | 9.44 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Stock Option | Disposal | 75,000 | 0 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 10,072 | 60.47 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 25,000 | 3.1 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 105,000 | 4.75 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 61,652 | 60.08 |
| Mar 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 43,348 | 59.26 |
| Jan 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Share Option (Right to Buy) | Acquisition | 350,000 | 0 |
| Jan 9, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Restricted Share Units | Acquisition | 20,000 | 0 |
| Jan 9, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Restricted Share Units | Acquisition | 15,000 | 0 |
| Jan 9, 2026 | DIFABIO, ANDREA | Chief Legal Officer | Share Option (Right to Buy) | Acquisition | 80,000 | 0 |
| Jan 9, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Restricted Share Units | Acquisition | 65,000 | 0 |
| Jan 9, 2026 | CLINE, DARREN S | Chief Commercial Officer | Share Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jan 9, 2026 | CLINE, DARREN S | Chief Commercial Officer | Restricted Share Units | Acquisition | 20,000 | 0 |
| Jan 9, 2026 | KENNEY, CHRISTOPHER JOHN | Chief Medical Officer | Share Option (Right to Buy) | Acquisition | 100,000 | 0 |
| Jan 2, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 37,938 | 44.4 |
| Jan 2, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Stock Option (Right to Buy) | Disposal | 40,000 | 0 |
| Jan 2, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 2,062 | 44.93 |
| Jan 2, 2026 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Acquisition | 40,000 | 7.49 |
| Dec 8, 2025 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 2,010 | 46.32 |
| Dec 8, 2025 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 8,820 | 45.59 |
| Dec 5, 2025 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 14,375 | 45.03 |
| Nov 28, 2025 | MORTIMER, IAN | Director, PRESIDENT & CEO | Common Shares | Disposal | 97 | 45.01 |
| Oct 15, 2025 | KELLY, THOMAS PATRICK | Chief Financial Officer | Share Option (Right to Buy) | Acquisition | 225,000 | 0 |
| Oct 15, 2025 | KELLY, THOMAS PATRICK | Chief Financial Officer | Restricted Share Units | Acquisition | 30,000 | 0 |
| Oct 1, 2025 | MORTIMER, IAN | Director, PRESIDENT, CEO & INTERIM CFO | Stock Option (Right to Buy) | Disposal | 25,000 | 0 |
| Oct 1, 2025 | MORTIMER, IAN | Director, PRESIDENT, CEO & INTERIM CFO | Common Shares | Disposal | 25,000 | 40.16 |
| Oct 1, 2025 | MORTIMER, IAN | Director, PRESIDENT, CEO & INTERIM CFO | Common Shares | Acquisition | 25,000 | 7.69 |